AJP - Endocrinology and Metabolism, Vol 251, Issue 1 127-E133, Copyright © 1986 by American Physiological Society

ARTICLES

Galanin: a novel pancreatic neuropeptide

B. E. Dunning, B. Ahren, R. C. Veith, G. Bottcher, F. Sundler and G. J. Taborsky Jr

Immunofluorescent staining for galanin in canine pancreatic tissue was performed together with an evaluation of the effects of synthetic galanin on pancreatic output of glucagon, somatostatin, and insulin in pentobarbital-anesthetized dogs. A dense network of galaninlike immunoreactive nerve fibers was visualized in association with the islets of Langerhans and occasional galanin immunoreactive fibers were seen to course through the exocrine parenchyma of dog pancreas. During intravenous infusion of synthetic porcine galanin (25 pmol X kg-1 X min-1) pancreatic glucagon output rapidly doubled, and the output of both somatostatin and insulin decreased by 70%. Because arterial and pancreatic venous catecholamine levels remained unchanged, the effects on hormone secretion were not secondary to activation of the sympathetic nervous system. The direct pancreatic action of galanin was confirmed by infusing a peripherally ineffective dose of galanin (0.25 pmol X kg-1 X min-1) into the pancreatic artery, which also stimulated glucagon (+90%) and suppressed somatostatin (-50%) and insulin (-70%) release. The presence of galaninlike immunoreactive neurons in dog islets, together with the direct action of galanin on pancreatic hormone release, suggest that this recently discovered peptide could serve as an important neuromodulator of endocrine pancreatic function.

This article has been cited by other articles:

				K. Igawa, M. Mugavero, M. Shiota, D. W. Neal, and A. D. Cherrington Insulin Sensitively Controls the Glucagon Response to Mild Hypoglycemia in the Dog Diabetes, October 1, 2002; 51(10): 3033 - 3042. [Abstract] [Full Text] [PDF]

				N. Flattem, K. Igawa, M. Shiota, M. G. Emshwiller, D. W. Neal, and A. D. Cherrington {alpha}- and {beta}-Cell Responses to Small Changes in Plasma Glucose in the Conscious Dog Diabetes, February 1, 2001; 50(2): 367 - 375. [Abstract] [Full Text]

				F. C. Schuit, P. Huypens, H. Heimberg, and D. G. Pipeleers Glucose Sensing in Pancreatic {beta}-Cells: A Model for the Study of Other Glucose-Regulated Cells in Gut, Pancreas, and Hypothalamus Diabetes, January 1, 2001; 50(1): 1 - 11. [Abstract] [Full Text]

				T. O. Mundinger and G. J. Taborsky Jr. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E390 - E397. [Abstract] [Full Text] [PDF]

				L. W. Fitzgerald, J. P. Patterson, D. S. Conklin, R. Horlick, and B. L. Largent Pharmacological and Biochemical Characterization of a Recombinant Human Galanin GALR1 Receptor: Agonist Character of Chimeric Galanin Peptides J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 448 - 456. [Abstract] [Full Text]

				S. Wang, C. He, T. Hashemi, and M. Bayne Cloning and Expressional Characterization of a Novel Galanin Receptor. IDENTIFICATION OF DIFFERENT PHARMACOPHORES WITHIN GALANIN FOR THE THREE GALANIN RECEPTOR SUBTYPES J. Biol. Chem., December 19, 1997; 272(51): 31949 - 31952. [Abstract] [Full Text] [PDF]

				T. O. Mundinger, C. B. Verchere, D. G. Baskin, M. R. Boyle, S. Kowalyk, and G. J. Taborsky Jr. Galanin is localized in sympathetic neurons of the dog liver Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1194 - E1202. [Abstract] [Full Text] [PDF]

				S. Wang, T. Hashemi, C. He, C. Strader, and M. Bayne Molecular Cloning and Pharmacological Characterization of a New Galanin Receptor Subtype Mol. Pharmacol., September 1, 1997; 52(3): 337 - 343. [Abstract] [Full Text]